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Abstract. Attempts to quantify the epidemiologic and economic burden of malaria have so far neglected to specifi-
cally address the burden of epidemic malaria. Moreover, the data on the effectiveness and cost-effectiveness of inter-
ventions in epidemics is extremely limited. Answering such key questions in an epidemic prone context is more
challenging than doing so in endemic areas. Using the limited data available, we estimate that in Africa, there are more
than 12 million malaria episodes and 155,000−310,000 malaria deaths per year attributable to epidemics if control options
are not implemented or well timed, which is equivalent to some 4% of estimated annual malaria cases worldwide and
12−25% of estimated annual worldwide malaria deaths, including up to 50% of the estimated annual worldwide malaria
mortality in persons > 15 years of age. The possible economic impact of malaria epidemics is described and the limited
evidence on the effectiveness and cost-effectiveness of interventions in areas of low or seasonal transmission is reviewed.
INTRODUCTION
Plasmodium falciparum malaria is a life-threatening dis-
ease for individuals with low immunity. Communities that are
not normally exposed to high rates of malaria transmission
are therefore vulnerable to explosive epidemics that can
cause high case fatality rates among all age groups. Epidemics
can be defined by their main causal factors and in this paper
we concentrate on those triggered predominately by climate
or weather.
In spite of their severity, research on malaria epidemics is
limited. Estimates of the population at risk of weather or
climate dependent malaria epidemics in Africa are contradic-
tory which makes estimation of the epidemiologic burden of
epidemics problematic. Very little is known about the eco-
nomic burden of epidemics. The current lack of accurate
documentation of the epidemic malaria burden and its eco-
nomic impact means that planning and targeting of resources
is uncertain and epidemics may not receive the attention or
resources that they may deserve. In particular, the severe
dearth of information regarding the cost-effectiveness of pre-
vention and control interventions in epidemic prone contexts
means that policy makers cannot make resource allocation
decisions based on sound evidence.
In this paper, we attempt to bring together the limited
quantitative data on the epidemiology of epidemic malaria
and use this in conjunction with estimates of the population
living in malaria-risk areas to quantify the epidemiologic bur-
den of malaria epidemics. The main difficulties in quantifying
the burden of epidemic malaria are discussed along with the
resulting implications for measuring the economic burden of
malaria epidemics. The evidence relating specifically to the
economic burden of epidemics and the cost and effectiveness
of interventions in epidemic settings is then reviewed to iden-
tify gaps and priorities for future research.
MATERIALS AND METHODS
To estimate the epidemiologic burden of malaria epidem-
ics, we first present a definition of the types of malaria epi-
demics and identify those included in this analysis. On the
basis of this definition, we examine available estimates of the
population at risk of epidemics. Estimates of the frequency of
occurrence of epidemics are obtained from the literature and
applied to our chosen at risk population estimate. We then go
on to examine the possible consequences of these epidemics
in terms of morbidity and mortality using available figures
and place our results in the context of estimated annual
worldwide malaria mortality.
A forthcoming review has identified that quantitative esti-
mates of the economic burden of epidemic malaria are pres-
ently lacking.1 We therefore describe the levels at which the
economic impact of epidemics may be felt and provide some
quantitative evidence from the gray literature where avail-
able.
A literature review was carried out to identify published
studies on the effectiveness and cost-effectiveness of malaria
interventions in areas of low, seasonal, or epidemic malaria
transmission. The results of this review are presented and
discussed.
Definition of epidemics. Malaria epidemics can be catego-
rized on the basis of their main causal factors2 (Figure 1).
First, they may be caused by climate anomalies (for example
excessive or prolonged rainfall or unusual increases in tem-
perature), often occurring in arid or semi-arid zones where
the human population is relatively or completely non-
immune. Second, in other areas, malaria transmission may be
strongly seasonal with some degree of inter-annual variation
caused by normal variations in climatology, perhaps as the
result of meteorologic phenomena such as strong El Niño
Southern Oscillation events that are commonly associated
with drought or floods and higher than average temperature.3
Third, epidemics may occur during complex emergency situ-
ations where normal malaria transmission might be exacer-
bated by sudden population movements, war, and political
instability. A neglect or breakdown in control activities may
also give previously controlled malaria the opportunity to re-
emerge, leading to a subsequent increase in transmission and
endemicity lasting for several transmission seasons.2 What-
ever their cause, the impact of malaria epidemics is greatest
when they follow periods of drought and famine when popu-
lations are most vulnerable.4
In this paper, we estimate the burden of the first two types
of epidemics described previously. These can be broadly cat-
egorized as occurring due to abnormal meteorological condi-
tions and as such have been described as occurring in “quasi-
regular cycles.”2 The burden of epidemics occurring in com-
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plex emergencies or as a result of a breakdown in control
activities is excluded since they are not obviously cyclical or
regular in nature and therefore cannot be estimated using this
methodology.
Population at risk. The duration of the malaria transmis-
sion season can be taken as a rough proxy for the likelihood
of epidemics occurring. Generally, as the transmission season
gets shorter, the risk of epidemics increases. In Africa, the
areas with a shorter transmission season tend to be located
across the Sahelean belt, down through the horn of Africa
into east Africa and throughout southern Africa.
Overall estimates of the population at risk of climate de-
pendent malaria epidemics in Africa vary depending on the
method and data used. Snow and others estimated that the
population exposed to epidemic malaria risk in Africa for
1995 was approximately 74 million.5 A World Health Orga-
nization (WHO) estimate determined in 1996 by country ex-
pert opinion based on historical malaria incidence data and
knowledge of risk factors estimated the same figure to be
approximately 112 million.6 This figure has recently been re-
calculated using United Nations population data for 2001, and
the resulting estimate is 124.7 million (Kawano M, meeting of
the Roll Back Malaria Technical Support Network on Epi-
demics, Leysin, Switzerland, December 2003). Testing and
validation of approaches to measuring the population at risk
of malaria epidemics are planned.7 However, for the purpose
of this study, we chose to use the updated WHO estimate
since it uses more recent population data. Table 1 provides a
country-by-country breakdown of the population estimated
to live in areas prone to or at risk of malaria epidemics
throughout Africa according to these calculations.
Epidemiologic burden of malaria epidemics. Malaria epi-
demics can recur in cycles of varying length caused by differ-
ent precipitating factors. It is therefore difficult to calculate a
precise average annual epidemiologic burden of disease.
However, most weather or climate driven epidemic follow
cycles of 2−7 years reflecting the periodicity of abnormal me-
teorologic conditions.2
It has been estimated that each person will have approxi-
mately 0.5 malaria episodes per epidemic.2 Assuming (con-
servatively) that epidemics occur on average every five
years,8 this gives an estimated 0.1 episodes of malaria per
person per year for the population living in areas at risk of
epidemics. Multiplying this by the population living in areas
at risk of malaria epidemics in gives an estimated 12.4 million
malaria episodes per year attributable to epidemics in Africa,
which is equivalent to some 4% of annual malaria cases
worldwide.9
Since epidemics occur in populations with little or no im-
munity, an estimated 5% of cases may progress to severe
malaria, which has a case fatality rate of approximately 10%
in reasonably well-equipped referral facilities.10 In epidemic
situations, facilities are likely to be under equipped, over
used, and under staffed. Staff may be caught unprepared and
with insufficient drugs, and patients may be more vulnerable
due to pre-existing malnutrition. All these factors contribute
to an increased case fatality rate for severe malaria (defined
according to WHO criteria11) of perhaps up to 25−50% in
epidemic situations.
Applying these figures to the 12.4 million epidemic-related
episodes per year results in an estimated 620,000 severe cases
per year of which up to 155,000−310,000 may result in death.
This is the equivalent of 12−25% of the annual worldwide
malaria deaths, including up to 50% of the estimated annual
worldwide malaria mortality in persons > 15 years of age.
In addition to the components of the direct epidemiologic
burden of malaria epidemics described earlier, there is likely
to be an increase in the incidence of low birth weight babies
and other complications arising from malaria in pregnancy
following epidemics. For example, during the malaria epi-
demic in Sri Lanka in 1934−1935, a case fatality rate of 13%
was recorded among pregnant women and the rate of fetal
loss or neonatal death was almost 70%.12,13 In an unstable
FIGURE 1. Classification of major malaria epidemic types.25 The
top panel shows the pattern of cases in a true epidemic. The middle
panel shows how cases may occur in epidemics caused by unusual
seasonal transmission. The bottom panel shows epidemics caused by
a neglect or breakdown in malaria control and/or population move-
ments, both of which may or may not be linked to complex emer-
gencies.
TABLE 1













Angola 13,527,000 35 4,734,450
Botswana 1,553,000 40 621,200
Burundi 6,501,000 50 3,250,500
Cape Verde 436,000 50 218,000
Chad 8,134,000 15 1,220,100
DR* Congo 52,521,000 10 5,252,100
Eritrea 3,815,000 60 2,289,000
Ethiopia 64,458,000 50 32,229,000
Kenya 31,292,000 25 7,823,000
Madagascar 16,436,000 50 8,218,000
Mali 11,676,000 20 2,335,200
Mauritania 2,746,000 40 1,098,400
Mauritius 1,170,000 40 468,000
Mozambique 18,644,000 20 3,728,800
Namibia 1,787,000 40 714,800
Niger 11,226,000 20 2,245,200
Rwanda 7,948,000 50 3,974,000
Senegal 9,661,000 10 966,100
Somalia 9,156,000 50 4,578,000
South Africa 43,791,000 5 2,189,550
Sudan 31,809,000 50 15,904,500
Swaziland 937,000 40 374,800
Tanzania 35,964,000 25 8,991,000
Uganda 24,022,000 10 2,402,200
Zambia 10,648,000 50 5,324,000
Zimbabwe 12,851,000 28 3,598,280
Total 432,709,000 124,748,180
* DR  Democratic Republic.
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transmission area on the northwestern border area of Thai-
land, Plasmodium falciparum malaria was the main cause of
maternal deaths before the institution of antenatal clinic pro-
grams (White N, unpublished data), and pregnant women
were found to be two times more likely to develop severe
malaria than non-pregnant women.14 An epidemic in Rwanda
in 1998 led to a four-fold increase in malaria admissions
among pregnant women and a five-fold increase in maternal
deaths due to malaria.13 A study in the highlands of Mada-
gascar found that although a greater percentage of low birth
weights was recorded at lowland clinics than at highland ones
(17.1% and 9.7%, respectively), the relative risk of low birth
weight linked to placental infection was found to be far
greater in the highlands than in the lowlands.15 In Ethiopia,
placental parasitemia was associated with an increased risk of
prematurity (relative risk  3.9) and a seven-fold increased
risk of stillbirths in areas of unstable transmission.16
Economic burden of malaria epidemics. The major prob-
lem in estimating the economic burden of malaria epidemics
is that it is difficult to estimate the economic impact of the
problem without a sound understanding of the epidemiologic
burden. However, in addition to this, fundamental questions
relating to the economic impact of epidemics at all levels of
the economy remain unanswered.
There is no recent evidence from Africa on the macroeco-
nomic impact of epidemics, although it is likely that epidem-
ics, or the possibility of epidemics, may deter or reverse eco-
nomic growth and development. For example, in the private
sector in highland tea or coffee estates, the impact of malaria
epidemics on the productivity, profitability, and growth of
companies remain unquantified, although recently work has
begun to quantify the cost of malaria epidemics on a sugar
estate and orange plantation in Ethiopia (Ministry of Health,
Ethiopia). In the public sector, epidemics may impose large
political and opportunity costs on governments or Ministries
of Health, who may have to divert funds from other areas to
deal with large-scale epidemic emergencies. A 1996−1997 ma-
laria epidemic in one district of Zimbabwe was estimated to
add approximately US$290,000 to the direct costs of malaria
control to the Ministry of Health alone, when compared with
costs in the previous, non-epidemic, year (Worrall E, Hon-
goro C, unpublished data). Aside from this estimate, the di-
rect and indirect costs which malaria epidemics impose on
governments remain largely unquantified.
The costs of epidemics to communities and households are
not well documented. Investment and community level devel-
opment may be undermined or wiped out by epidemics. It
may also be deterred completely simply by the threat of epi-
demics occurring. Community structures and coping strate-
gies may be stretched to the limit or breakdown in serious
epidemic situations. At the household or individual level, a
lack of resources to cope with or mitigate the situation may
cause additional suffering and force negative economic deci-
sions such as the panic sales of assets and increasing debts to
pay for care or funerals of adults as well as children. The
threat of epidemics may also influence decisions relating to
crop choice, family planning, and the level of investment. The
long-term effects of these decisions on individual and house-
hold welfare are unknown.
Review of effectiveness and cost-effectiveness of interven-
tions in epidemics. The evidence relating to the effectiveness
and cost-effectiveness of interventions in areas of unstable,
low, or epidemic malaria transmission is extremely limited
and at times mixed or contradictory.
The accuracy of rainfall and temperature as predictors of
malaria epidemics in different epidemiologic and geographi-
cal settings still needs to be established. However, effective
epidemic prediction tools, or “malaria early warning systems”
(MEWS), have the potential to improve the timeliness and
thereby cost-effectiveness of interventions such as indoor re-
sidual house spraying,3 and possibly, other preventive or con-
trol interventions associated with epidemic preparedness such
as drug/supplies stock maintenance. However, the economic
benefits of malaria early warning systems have so far only
been evaluated hypothetically using a modeling approach.
(Worrall E, 2001. An Economic Evaluation of Malaria Early
Warning Systems in Africa: A Population Dynamic Modelling
Approach. PhD Thesis, Liverpool, United Kingdom: Univer-
sity of Liverpool). There is currently no evidence regarding
the cost or effectiveness of early detection indicators such as
monitoring unusual increases in malaria patients, blood slide
positivity, or demand for blood transfusions. It is likely that
these options would be relatively low cost, but their impact on
potential epidemics would be limited by the willingness and
capacity of the system to respond to such indicators with ap-
propriate interventions within the given lead time.
The evidence on insecticide-treated nets (ITNs) compared
with indoor residual spraying (IRS) is mixed when comparing
the cost-effectiveness in areas of low or seasonal transmission.
In a low transmission area of South Africa, ITNs were found
to be more effective but more expensive.17 In contrast to this
result, IRS was found to be both more effective and cheaper
than ITNs in an area of seasonal transmission in the Kenyan
highlands.18 As a tool for preventing anemia in pregnancy,
ITNs were found to be ineffective in a high transmission area
of Kenya, but did reduce anemia in an area of low transmis-
sion on the Thailand/Burma (Myanmar) border.19,20 Intermit-
tent preventive treatment for the prevention of malaria and
anemia in pregnancy has been found to be effective in high
transmission areas in Africa,21 but there are no data on its
effectiveness in low transmission areas and during epidemics.
Weekly chemoprophylaxis has been found to be effective for
prevention of malaria in pregnancy in a low transmission area
in Thailand,22 and studies on its effectiveness in a low trans-
mission area of Madagascar are ongoing.15 Data on the cost-
effectiveness (as opposed to effectiveness) of these interven-
tions in unstable transmission areas are not available.
DISCUSSION
Estimating the epidemiologic burden of malaria epidemics
is more challenging than estimating or measuring the burden
of endemic malaria for a number of reasons. First, different
definitions are used to describe epidemics and these may vary
according to epidemiologic settings. Currently, no standard-
ized thresholds for the declaration of epidemics have been
agreed upon since they strongly depend on local epidemio-
logic situations. Efforts are ongoing to field test and validate
epidemic thresholds to identify unusual deviations from nor-
mal figures in various epidemiologic settings/conditions espe-
cially in Africa.7
Second, the different types of epidemics mean that in some
instances, their impact will be impossible to estimate in an
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accurate manner. For example, in complex emergency situa-
tions, it may be difficult to separate morbidity and mortality
caused by malaria from that caused by other factors. At-
tempts have been made by some non-governmental organi-
zations (e.g., International Rescue Committee23 and Médicins
sans Frontières24) to quantify the additional impact of civil
war and emergencies on mortality, but only in endemic set-
tings.
Third, there are many potential problems relating to insuf-
ficient or unreliable data. For example, surveillance data on
epidemics is often not specifically collected or recorded be-
cause epidemics may be over before health services have had
time to intervene, or because in severe situations, reporting
procedures may break down. Epidemics also tend to affect
marginalized and underserved populations that may be out-
side of the usual reporting systems. In some instances, more
cases will go unreported than usual because families may be
unable to attend facilities for financial or health reasons, both
of which will be compounded in a severe epidemic. In other
instances, a free-drugs policy in government health services
during times of epidemics may attract many of the patients
who would normally have gone to private sector providers,
thus affecting comparability of such data. Proper post-
epidemic assessment exercises, which would address many of
these issues, are rarely undertaken.
Fourth, the effects of malaria in pregnancy in epidemic
situations that will continue months after the epidemic is con-
sidered to be over are only just beginning to be understood
and consequently may be underestimated or ignored com-
pletely.
Finally, epidemics are heterogeneous in nature; the size of
the population affected, the frequency and duration of occur-
rence, and the severity of epidemic outbreaks will all vary
depending on local conditions and response capacity. This
makes it difficult to extrapolate burden estimates from the
limited data that are currently available.
Most epidemics by their nature are cyclical and are predict-
able only on a probabilistic basis, which makes it difficult to
plan in advance for a study on the cost-effectiveness of an
intervention in an epidemic situation. Any analysis must
therefore be done on an opportunistic or retrospective basis
(post-assessment field analysis exercise), or through the use
of modeling techniques. Measuring effectiveness will be par-
ticularly problematic because pre-intervention and post-
intervention comparison is not appropriate since the number
of malaria cases may not be constant or follow an annual
pattern. It is also likely to be difficult to find suitable control
areas for comparison between interventions. Establishing the
counter factual (what would have happened with or without
the intervention in question) is also difficult in epidemic situ-
ations because estimates of effectiveness may not accurately
capture the transmission reducing effects of an intervention.
This is of critical importance in bringing epidemics under con-
trol. Moreover, available evidence on effectiveness of particu-
lar interventions is likely to be based on the effectiveness of
interventions in endemic settings, which may not be compa-
rable. Finally, even if an economic evaluation such as a cost-
effectiveness analysis can be satisfactorily carried out, the
transferability of the results to other settings will be limited by
the unique nature of many epidemics and the settings in
which they occur.
CONCLUSION
The epidemiologic and economic impact of epidemic ma-
laria is likely to be different from that of endemic malaria. To
move forward with accurately estimating the burden of epi-
demic malaria, it must be recognized that the evidence on the
economic impact, effectiveness, and cost-effectiveness of in-
terventions obtained from endemic settings is not necessarily
applicable to areas prone to unstable or epidemic transmis-
sion. While substantial progress has been made over recent
years, thanks to the support of the Roll Back Malaria initia-
tive, in estimating the burden of malaria, the human and eco-
nomic burden of malaria epidemics remains largely unquan-
tified, although our estimates show that it is clearly signifi-
cant: epidemic malaria in Africa alone may be causing up to
25% of annual malaria mortality worldwide, including up to
50% of adult malaria deaths. In particular, the effects of ma-
laria in pregnancy during and following epidemics have been
neglected.
To complement these preliminary estimates, there is an
urgent need to carry out high-quality, multidisciplinary re-
search into the epidemiologic and socioeconomic impact of
malaria epidemics. Routine data collection, reporting, and
post-epidemic assessment activities must be strengthened and
expanded to generate data on the burden of epidemics. This
data can then be collated and triangulated with broad quan-
titative estimates such as that presented in this paper to gen-
erate reliable and useful data on malaria epidemics. The use
of detailed post-epidemic assessments including cost-
effectiveness analyses of interventions and other innovative
techniques such as simulation modeling will be necessary to
establish an evidence base on the cost-effectiveness of inter-
ventions to control malaria epidemics in a variety of epide-
miologic and operational settings. This evidence is required to
support planning and policy decisions in epidemic emergency
situations that may otherwise be driven by panic and influ-
enced heavily by the media.
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